Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorna Rodriguez-Rodriguez

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of the National Cancer Institute|November 21, 2017
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric CancerAnshuman Panda, Janice M Mehnert, Kim M Hirshfield, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targetingEric Hee Jun Lee, Cody Cullen, John P Murad, et al.
Nature Communications|November 18, 2018
RET rearrangements are actionable alterations in breast cancerBhavna S Paratala, Jon H Chung, Casey B Williams, et al.
Scientific Reports|February 28, 2025
Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancerVeronica Jones, Hongwei Holly Yin, Yate-Ching Yuan, et al.
Annals of Surgical Oncology|September 14, 2023
Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian CancerRosemary N Senguttuvan, Nicole Lugo Santiago, Ernest S Han, et al.
Nature Communications|August 7, 2023
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targetingEric Hee Jun Lee, John P Murad, Lea Christian, et al.
JCO Precision Oncology|March 31, 2022
Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian CancerThanh H Dellinger, Ernest S Han, Mustafa Raoof, et al.
Cancer Research|May 23, 2025
Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeElizabeth A Raupach, Apurva M Hegde, Krystine Garcia-Mansfield, et al.
The Oncologist|August 28, 2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersKim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.
International Journal of Epidemiology|April 10, 2013
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studiesWeiva Sieh, Shannon Salvador, Valerie McGuire, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of the National Cancer Institute|November 21, 2017
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric CancerAnshuman Panda, Janice M Mehnert, Kim M Hirshfield, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targetingEric Hee Jun Lee, Cody Cullen, John P Murad, et al.
Nature Communications|November 18, 2018
RET rearrangements are actionable alterations in breast cancerBhavna S Paratala, Jon H Chung, Casey B Williams, et al.
Scientific Reports|February 28, 2025
Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancerVeronica Jones, Hongwei Holly Yin, Yate-Ching Yuan, et al.
Annals of Surgical Oncology|September 14, 2023
Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian CancerRosemary N Senguttuvan, Nicole Lugo Santiago, Ernest S Han, et al.
Nature Communications|August 7, 2023
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targetingEric Hee Jun Lee, John P Murad, Lea Christian, et al.
JCO Precision Oncology|March 31, 2022
Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian CancerThanh H Dellinger, Ernest S Han, Mustafa Raoof, et al.
Cancer Research|May 23, 2025
Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeElizabeth A Raupach, Apurva M Hegde, Krystine Garcia-Mansfield, et al.
The Oncologist|August 28, 2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersKim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.
International Journal of Epidemiology|April 10, 2013
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studiesWeiva Sieh, Shannon Salvador, Valerie McGuire, et al.
Pageof 7